Pharmacoproteomics reveal novel protective activity of bromodomain containing 4 inhibitors on vascular homeostasis in TLR3-mediated airway remodeling
- 10 June 2019
- journal article
- research article
- Published by Elsevier BV in Journal of Proteomics
- Vol. 205, 103415
- https://doi.org/10.1016/j.jprot.2019.103415
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Science Foundation
This publication has 50 references indexed in Scilit:
- Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patientsJournal of Allergy and Clinical Immunology, 2013
- Pulmonary fibrosis: patterns and perpetratorsJCI Insight, 2012
- RelA Ser276 Phosphorylation-Coupled Lys310 Acetylation Controls Transcriptional Elongation of Inflammatory Cytokines in Respiratory Syncytial Virus InfectionJournal of Virology, 2011
- Phylogenetic-based propagation of functional annotations within the Gene Ontology consortiumBriefings in Bioinformatics, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosisJCI Insight, 2009
- Characterization of exosome‐like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defenseThe FASEB Journal, 2009
- Airway Remodeling Measured by Multidetector CT Is Increased in Severe Asthma and Correlates With PathologySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2008
- The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?The International Journal of Biochemistry & Cell Biology, 2008
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008